87 related articles for article (PubMed ID: 12196123)
1. Troybodies and pepbodies.
Lunde E; Lauvrak V; Rasmussen IB; Schjetne KW; Thompson KM; Michaelsen TE; Brekke OH; Sollid LM; Bogen B; Sandlie I
Biochem Soc Trans; 2002 Aug; 30(4):500-6. PubMed ID: 12196123
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.
Baier G; Baier-Bitterlich G; Looney DJ; Altman A
J Virol; 1995 Apr; 69(4):2357-65. PubMed ID: 7533857
[TBL] [Abstract][Full Text] [Related]
3. Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies.
Lunde E; Western KH; Rasmussen IB; Sandlie I; Bogen B
J Immunol; 2002 Mar; 168(5):2154-62. PubMed ID: 11859101
[TBL] [Abstract][Full Text] [Related]
4. 'Troy-bodies': antibodies as vector proteins for T cell epitopes.
Lunde E; Rasmussen IB; Eidem JK; Gregers TF; Western KH; Bogen B; Sandlie I
Biomol Eng; 2001 Oct; 18(3):109-16. PubMed ID: 11566602
[TBL] [Abstract][Full Text] [Related]
5. The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.
Rasmussen IB; Lunde E; Michaelsen TE; Bogen B; Sandlie I
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10296-301. PubMed ID: 11517321
[TBL] [Abstract][Full Text] [Related]
6. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
[TBL] [Abstract][Full Text] [Related]
7. CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4+ T-cell responses.
Rasmussen IB; Oynebråten I; Høydahl LS; Flobakk M; Lunde E; Michaelsen TE; Bogen B; Sandlie I
Protein Eng Des Sel; 2012 Mar; 25(3):89-96. PubMed ID: 22233931
[TBL] [Abstract][Full Text] [Related]
8. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
10. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
[TBL] [Abstract][Full Text] [Related]
11. "Troy-bodies": recombinant antibodies that target T cell epitopes to antigen presenting cells.
Lund E; Rasmussen IB; Western KH; Eidem JK; Sandlie I; Bogen B
Int Rev Immunol; 2001 Oct; 20(5):647-73. PubMed ID: 11890617
[TBL] [Abstract][Full Text] [Related]
12. Human CD14 is an efficient target for recombinant immunoglobulin vaccine constructs that deliver T cell epitopes.
Tunheim G; Schjetne KW; Fredriksen AB; Sandlie I; Bogen B
J Leukoc Biol; 2005 Mar; 77(3):303-10. PubMed ID: 15576418
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
Denkberg G; Lev A; Eisenbach L; Benhar I; Reiter Y
J Immunol; 2003 Sep; 171(5):2197-207. PubMed ID: 12928363
[TBL] [Abstract][Full Text] [Related]
14. T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements.
Wiertz EJ; van Gaans-van den Brink JA; Schreuder GM; Termijtelen AA; Hoogerhout P; Poolman JT
J Immunol; 1991 Sep; 147(6):2012-8. PubMed ID: 1716291
[TBL] [Abstract][Full Text] [Related]
15. Recombinant antibodies as carrier proteins for sub-unit vaccines: influence of mode of fusion on protein production and T-cell activation.
Eidem JK; Rasmussen IB; Lunde E; Gregers TF; Rees AR; Bogen B; Sandlie I
J Immunol Methods; 2000 Nov; 245(1-2):119-31. PubMed ID: 11042289
[TBL] [Abstract][Full Text] [Related]
16. Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells.
Lunde E; Munthe LA; Vabø A; Sandlie I; Bogen B
Nat Biotechnol; 1999 Jul; 17(7):670-5. PubMed ID: 10404160
[TBL] [Abstract][Full Text] [Related]
17. Single-chain MHC class II molecules induce T cell activation and apoptosis.
Rhode PR; Burkhardt M; Jiao J; Siddiqui AH; Huang GP; Wong HC
J Immunol; 1996 Dec; 157(11):4885-91. PubMed ID: 8943392
[TBL] [Abstract][Full Text] [Related]
18. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease.
Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G
J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170
[TBL] [Abstract][Full Text] [Related]
19. Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
Karbach J; Pauligk C; Bender A; Gnjatic S; Franzmann K; Wahle C; Jäger D; Knuth A; Old LJ; Jäger E
Int J Cancer; 2006 Feb; 118(3):668-74. PubMed ID: 16152624
[TBL] [Abstract][Full Text] [Related]
20. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I
Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
